Showing results (11-20 of 33) with videos related to
Sort By:
Pageof 4
Advances in Therapy|February 27, 2025
Application of a Value Framework to Determine the Value of Prophylaxis Versus On-Demand Treatment in Adults with Hemophilia A in ChinaBaoying Tan, Ailing Lin, Rong Han, et al.Lancet (London, England)|October 22, 2008
Reform of how health care is paid for in China: challenges and opportunitiesShanlian Hu, Shenglan Tang, Yuanli Liu, et al.Plos One|June 16, 2017
Risk factors and protective factors associated with incident or increase of frailty among community-dwelling older adults: A systematic review of longitudinal studiesZeyun Feng, Marjolein Lugtenberg, Carmen Franse, et al.Clinicoeconomics and Outcomes Research : CEOR|February 18, 2017
The cost-effectiveness of a NSCLC patient assistance program for pemetrexed maintenance therapy in People's Republic of ChinaQiang Shi, Shanlian Hu, Wesley E Furnback, et al.Patient Related Outcome Measures|October 4, 2023
Disutilities Associated with Intravenous Iron Infusions: Results from a Time Trade-off Survey and Diminishing Marginal Utility Model for Treatment Attributes in ChinaShanlian Hu, Depei Wu, Jing Wu, et al.Lancet (London, England)|March 6, 2012
Early appraisal of China's huge and complex health-care reformsWinnie Chi-Man Yip, William C Hsiao, Wen Chen, et al.Applied Health Economics and Health Policy|June 21, 2015
A Case Study of Pharmaceutical Pricing in China: Setting the Price for Off-Patent OriginatorsShanlian Hu, Yabing Zhang, Jiangjiang He, et al.Journal of Market Access & Health Policy|April 29, 2016
Drug pricing reform in China: analysis of piloted approaches and potential impact of the reformYixi Chen, Shanlian Hu, Peng Dong, et al.International Journal of Health Policy and Management|August 9, 2022
Quality and Performance Measurement in Primary Diabetes Care: A Qualitative Study in Urban ChinaAlon Rasooly, Yancen Pan, Zhenqing Tang, et al.Value in Health Regional Issues|April 29, 2018
A Novel Estimation of the Impact of Treatment with Entecavir on Long-Term Mortality, Morbidity, and Health Care Costs of Chronic Hepatitis B in ChinaLai Wei, Shanlian Hu, Jinlin Hou, et al.Pageof 4